BCL-2 Proteins and the IGF-1 Receptor

本项目的目的是明确细胞凋亡中的两个主要角色，I型胰岛素样生长因子受体(IGF-IR)和Bcl2蛋白家族之间的关系，特别是Bclxl和Bad。我们实验室和文献的初步结果表明，这两个系统之间存在联系，我们打算探索胰岛素样生长因子-IR和这些蛋白在细胞凋亡过程中相互调控的机制(S)。我们将重点介绍两种不同的制度，这两种制度各有优缺点。在第一个模型中，我们将使用小鼠胚胎成纤维细胞(MEF)在锚定独立的条件下，因为被拒绝附着到底物的细胞通常比单层培养中的细胞更容易发生凋亡(失巢凋亡)，而且当细胞处于锚定独立的条件下时，IGF-IR的保护作用更显著。在第二个模型中，我们将使用一种小鼠造血细胞系，即在IGF-IR信号通路方面具有独特特征的32D细胞。此外，利用一个新的令人兴奋的发现，即IGF-I对造血细胞分化的诱导，我们将探索IGF系统中分化与细胞凋亡的关系，以及Bcl2家族的蛋白质如何调节分化。我的项目显然与其他3个项目在目标和机制方面都相关，并依赖于与Bruno Calabretta(32D细胞，分化)和Carlo Croce(针对Bcl-2蛋白质家族)的严格合作。我已经与Emad Alnemri进行了合作，当我们必须确定Caspase在IGF-IR的抗凋亡效应中的作用时，这种合作将重新开始。这些研究虽然是基础性的，但可能会导致实际应用(事实上，它们已经这样做了)，特别是在癌症领域。

The aims of this project are to define the relationships between two major players in apoptosis, the type 1 insulin-like growth factor receptor (IGF- IR) and the Bcl-2 family of proteins, especially Bcl-Xl and Bad. Preliminary results from our laboratory and from the literature indicate that there is a connection between theses two systems and we intend to explore the mechanism(s) by which the IGF-IR and these proteins modulate each other in the apoptotic process. We will focus on two different systems, both of which have their advantages and disadvantages. In the first model, we will use mouse embryo fibroblasts (MEF) in conditions of anchorage- independence, because cells denied attachment to a substratum are often more susceptible to apoptosis (anoikis) than cells in monolayer cultures, and because the protective effect of the IGF-IR is more striking when the cells are in conditions of anchorage independence. In the 2nd model, we will use a line of murine hemopoietic cells, 32D cells that have unique characteristics in regard to the signaling pathway of the IGF-IR. In addition, taking advantage of a new and exciting discovery, the induction by IGF-I of differentiation in hemopoietic cells, we will explore the relationship between differntiation and apoptosis in the IGF system, and how proteins of the Bcl-2 family may modify differentiation. My project is clearly related to the other 3 projects, both in terms of targets and mechanisms, and depends on a strict collaboration with Bruno Calabretta (32D cells, differentiation) and Carlo Croce (for the Bcl-2 family of proteins). I have already had a collaboration with Emad Alnemri, and this interation will be renewed when we will have to define the role of caspases in the anti=apoptotic effects of the IGF-IR. These investigations, while of a basic nature, could lead (as, in fact, they already have) to practical applications, especially in the field of cancer.